Inhibikase Therapeutics Inc Ordinary Shares (NASDAQ:IKT)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - IKT
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - IKT
- Market Cap$69.050m
- SymbolNASDAQ:IKT
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS45719W1062
Company Profile
Inhibikase Therapeutics Inc is a clinical stage pharmaceutical company developing therapeutics for Parkinson's Diseases and related disorders inside and outside the brain. Its pipeline product, IkT-148009, targets underlying disease mechanisms to reverse the course of Parkinson's disease and the GI complications of Parkinson's disease.
Latest IKT news
Currently there for this company. Visit our news hub for other news .